Merger Completed

Galera Therapeutics and Obsidian Therapeutics merger

US$414m equity value

Announced 14 Apr 2026 · NASDAQ: OBX

Advisers

Target
Obsidian Therapeutics
Acquirer
Galera Therapeutics
Target based in
United States
Buyer based in
United States
Completed
3 Aug 2026
Sector
Biotech
Tags
Biotech, Cell Therapy, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.